DocGo initiated with a Buy at BTIG

BTIG analyst David Larsen initiated coverage of DocGo with a Buy rating and $15 price target. During the pandemic, municipalities used DocGo to provide COVID testing and vaccinations for the homeless population, the analyst tells investors in a research note. The firm says the company has a “deep, and very robust,” technology platform that shows which care-units are available for services, where they are located, and the skills available within certain teams. The firm says DocGo continues to win larger contracts and can work across the entire healthcare and human services ecosystem to deliver value.